831 related articles for article (PubMed ID: 17574312)
21. Regulated antigen expression in live recombinant Salmonella enterica serovar Typhimurium strongly affects colonization capabilities and specific CD4(+)-T-cell responses.
Bumann D
Infect Immun; 2001 Dec; 69(12):7493-500. PubMed ID: 11705925
[TBL] [Abstract][Full Text] [Related]
22. The use of live attenuated Salmonella for oral vaccination.
Chatfield S; Roberts M; Li J; Starns A; Dougan G
Dev Biol Stand; 1994; 82():35-42. PubMed ID: 7958481
[TBL] [Abstract][Full Text] [Related]
23. Salmonella enterica serovar Typhimurium lacking hfq gene confers protective immunity against murine typhoid.
Allam US; Krishna MG; Lahiri A; Joy O; Chakravortty D
PLoS One; 2011 Feb; 6(2):e16667. PubMed ID: 21347426
[TBL] [Abstract][Full Text] [Related]
24. Peptidase N encoded by Salmonella enterica serovar Typhimurium modulates systemic infection in mice.
Patil V; Kumar A; Kuruppath S; Nandi D
FEMS Immunol Med Microbiol; 2007 Nov; 51(2):431-42. PubMed ID: 17877733
[TBL] [Abstract][Full Text] [Related]
25. The involvement of tumor necrosis factor in immunity to Salmonella infection.
Tite JP; Dougan G; Chatfield SN
J Immunol; 1991 Nov; 147(9):3161-4. PubMed ID: 1919009
[TBL] [Abstract][Full Text] [Related]
26. [Cellular immune responses specific for CD8+ T cell epitopes delivered by attenuated Salmonella typhimurium].
Zhang H; Jiao XA; Pan ZM; Zhang XM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Mar; 22(2):137-40. PubMed ID: 16507242
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of key virulence factors makes the Salmonella enterica serovar Typhimurium rfaH mutant a promising live-attenuated vaccine candidate.
Nagy G; Danino V; Dobrindt U; Pallen M; Chaudhuri R; Emödy L; Hinton JC; Hacker J
Infect Immun; 2006 Oct; 74(10):5914-25. PubMed ID: 16988271
[TBL] [Abstract][Full Text] [Related]
28. Construction of an attenuated Salmonella enterica serovar Paratyphi A vaccine strain harboring defined mutations in htrA and yncD.
Zhu C; Xiong K; Chen Z; Hu X; Li J; Wang Y; Rao X; Cong Y
Microbiol Immunol; 2015 Aug; 59(8):443-51. PubMed ID: 26084199
[TBL] [Abstract][Full Text] [Related]
29. Mouse models for assessing the cross-protective efficacy of oral non-typhoidal Salmonella vaccine candidates harbouring in-frame deletions of the ATP-dependent protease lon and other genes.
Matsui H; Fukiya S; Kodama-Akaboshi C; Eguchi M; Yamamoto T
J Med Microbiol; 2015 Mar; 64(Pt 3):295-302. PubMed ID: 25589672
[TBL] [Abstract][Full Text] [Related]
30. Role of T cells, TNF alpha and IFN gamma in recall of immunity to oral challenge with virulent salmonellae in mice vaccinated with live attenuated aro- Salmonella vaccines.
Mastroeni P; Villarreal-Ramos B; Hormaeche CE
Microb Pathog; 1992 Dec; 13(6):477-91. PubMed ID: 1363824
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of efficacy of a new live Salmonella Typhimurium vaccine candidate in a murine model.
Hur J; Kim MY; Lee JH
Comp Immunol Microbiol Infect Dis; 2011 Mar; 34(2):171-7. PubMed ID: 21111480
[TBL] [Abstract][Full Text] [Related]
32. The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs.
Martin C; Williams A; Hernandez-Pando R; Cardona PJ; Gormley E; Bordat Y; Soto CY; Clark SO; Hatch GJ; Aguilar D; Ausina V; Gicquel B
Vaccine; 2006 Apr; 24(17):3408-19. PubMed ID: 16564606
[TBL] [Abstract][Full Text] [Related]
33. [Attenuated Salmonella typhimurium as DNA delivery vehicle for DNA-mediated immunization].
He P; Chen H; Liu JX; Chen SY; Hu BY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep; 18(3):238-42. PubMed ID: 15640857
[TBL] [Abstract][Full Text] [Related]
34. Trichinella spiralis: intranasal immunization with attenuated Salmonella enterica carrying a gp43 antigen-derived 30mer epitope elicits protection in BALB/c mice.
Pompa-Mera EN; Yépez-Mulia L; Ocaña-Mondragón A; García-Zepeda EA; Ortega-Pierres G; González-Bonilla CR
Exp Parasitol; 2011 Dec; 129(4):393-401. PubMed ID: 21907709
[TBL] [Abstract][Full Text] [Related]
35. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.
Lasaro MO; Luiz WB; Sbrogio-Almeida ME; Ferreira LC
Vaccine; 2005 Mar; 23(19):2430-8. PubMed ID: 15752829
[TBL] [Abstract][Full Text] [Related]
36. Salmonella Typhimurium LPS mutations for use in vaccines allowing differentiation of infected and vaccinated pigs.
Leyman B; Boyen F; Van Parys A; Verbrugghe E; Haesebrouck F; Pasmans F
Vaccine; 2011 May; 29(20):3679-85. PubMed ID: 21419163
[TBL] [Abstract][Full Text] [Related]
37. Immune responses in BALB/c mice following immunization with aromatic compound or purine-dependent Salmonella typhimurium strains.
O'Callaghan D; Maskell D; Tite J; Dougan G
Immunology; 1990 Feb; 69(2):184-9. PubMed ID: 2106482
[TBL] [Abstract][Full Text] [Related]
38. Rational design of Salmonella-based vaccination strategies.
Spreng S; Dietrich G; Weidinger G
Methods; 2006 Feb; 38(2):133-43. PubMed ID: 16414270
[TBL] [Abstract][Full Text] [Related]
39. [Oral mixed DNA vaccine protects mice from infection of Toxoplasma gondii].
Cong H; Gu QM; Zhou HY; Guo L; Yang TT; He SY; Li Y; Zhao QL
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Jun; 23(3):159-62. PubMed ID: 16300008
[TBL] [Abstract][Full Text] [Related]
40. Cancer immunotherapy based on recombinant Salmonella enterica serovar Typhimurium aroA strains secreting prostate-specific antigen and cholera toxin subunit B.
Fensterle J; Bergmann B; Yone CL; Hotz C; Meyer SR; Spreng S; Goebel W; Rapp UR; Gentschev I
Cancer Gene Ther; 2008 Feb; 15(2):85-93. PubMed ID: 18084243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
